A5062417712- Pleural and Pulmonary Diseases
- Tuberculosis Research and Epidemiology
- Lymphatic Disorders and Treatments
- Gastrointestinal disorders and treatments
- Pericarditis and Cardiac Tamponade
- Infectious Diseases and Tuberculosis
- Occupational and environmental lung diseases
- Mechanical Circulatory Support Devices
- Soft tissue tumors and treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lymphadenopathy Diagnosis and Analysis
- Nosocomial Infections in ICU
- Antifungal resistance and susceptibility
- Infections and bacterial resistance
- Microscopic Colitis
- Vector-borne infectious diseases
- Chronic Myeloid Leukemia Treatments
- Mosquito-borne diseases and control
- Systemic Sclerosis and Related Diseases
- Vascular Malformations and Hemangiomas
- Infective Endocarditis Diagnosis and Management
- Chronic Lymphocytic Leukemia Research
- Head and Neck Anomalies
- Antimicrobial Resistance in Staphylococcus
Osakidetza
2021-2023
Biogipuzkoa Health Research Institute
2008-2023
Hospital San Pedro
1998-2018
Policlínica Gipuzkoa
2017
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
2008
Hospital Comarcal de Inca
2008
Diputación Foral de Gipuzkoa
2001
Civil Service
2001
Universidad de Las Palmas de Gran Canaria
2001
Tuberculous pleural effusion (TPE) is a paucibacillary manifestation of tuberculosis, so isolation Mycobacterium tuberculosis difficult, biomarkers being an alternative for diagnosis. Adenosine deaminase (ADA) the most cost-effective fluid marker and routinely used in high prevalence settings, whereas its value questioned areas with low prevalence. The lymphocyte proportion (LP) known to increase specificity ADA this We analyse diagnostic usefulness alone combination ≥ 40 U/l (ADA(40)) LP...
Screening strategies based on interferon-γ release assays in tuberculosis contact tracing may reduce the need for preventive therapy without increasing subsequent active disease.We conducted an open-label, randomized trial to test noninferiority of a 2-step strategy with tuberculin skin (TST) followed by QuantiFERON-TB Gold In-Tube (QFT-GIT) as confirmatory (the TST/QFT arm) standard TST-alone (TST targeting household contacts patients tuberculosis. Participants were 24 months after...
Objective To analyze the performance of adenosine deaminase in pleural fluid combined with other parameters routinely measured clinical practice and assisted by machine learning algorithms for diagnosis tuberculosis a low prevalence setting, secondly, to identify effusions that are non-tuberculous most likely malignant. Patients methods We prospectively analyzed 230 consecutive patients diagnosed lymphocytic exudative effusion from March 2013 June 2020. Diagnosis according composite...
Dasatinib is a tyrosine kinase inhibitor used for treatment of some specific types leukaemia. The development pleural effusion known adverse effect dasatinib and chylothorax exceptional. No case has been reported beyond 5 years extensive search an alternative diagnosis currently suggested in such scenario. underlying mechanism not clear. We describe woman on more than 10 who developed chylothorax. Drug withdrawal resolved the chylous effusion. were able to find 14 additional cases...
Transjugular intrahepatic portosystemic shunt (TIPS) is a minimally invasive procedure used for the decompression of portal pressure since early 1990s.Bacteremia with an infection TIPS or endotipsitis serious complication 32% mortality.To date and including present case, only 56 cases have been reported in literature.There are concerns regarding underdiagnosis.We report case patient recurrent bacteremia treated successfully our institution.In addition, previous were reviewed microbiological...